MORE►
Ben Lamm
Colossal Biosciences has re-engineered the egg. The company’s shell-less artificial egg system is shown alongside a developing embryo and one of the chicks successfully hatched from the 3D-printed incubation device. Colossal says the platform could support future conservation efforts and the de-extinction of giant birds such as the South Island Giant Moa. [Image: Colossal Biosciences]
Colossal Hatches Chicks, Cracks the Egg Problem for Giant Bird De‑Extinction
by Quincy Preston and Sandra Engelland | May 19, 2026
The Dallas biotech says the shell-less incubation platform could help revive species such as the South Island Giant Moa, whose massive eggs exceed the capacity of any living bird surrogate.
by Quincy Preston |
Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
by David Seeley |
Feb 3, 2026
"We're losing species at an alarming rate, and the world urgently needs a distributed network of global BioVaults—a true backup plan for life on Earth," said Ben Lamm, Colossal BioSciences' co-founder and CEO.
MORE►
by Quincy Preston |
Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE►
Andy Tang (left), a partner at Draper Associates, and Bobby Franklin, CEO of the National Venture Capital Association, speak onstage at Venture Dallas. [Photo: Grant Miller Photography/Venture Dallas]
‘There’s So Much Energy in Our Space’: Innovators, Investors Invigorate Sold-Out 2025 Venture Dallas Conference
by Glenn Hunter | Nov 5, 2025
From North Texas founders including John Carmack and Ben Lamm to investors like John Redgrave of DTX Ventures and Draper’s Andy Tang, the summit's speakers tackled hot topics from humanoid robots and tech transfer to AI, VC trends and Y’all Street. A call was also heard for more risk-taking by DFW’s innovation ecosystem: ‘We’ve got to be bravery hunters.’
MORE►
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by Venture Dallas |
Oct 23, 2025
Top executives at Nasdaq and Susser Bank celebrated high-growth potential companies contributing to region’s rise in entrepreneurship and innovation
sponsored by Venture Dallas
MORE►
by David Seeley |
Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
Colossal Co-Founder and CEO Ben Lamm (left) with Colossal Chief Biology Officer, Andrew Pask Ph.D. [Photo: Colossal]
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by Lance Murray | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE►
![The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]](https://s24806.pcdn.co/wp-content/uploads/2025/07/Colossal-Moa-360x203.jpg)
by Quincy Preston |
Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
by Quincy Preston |
Jun 26, 2025
While TIME put Maximum Effort and Waymo on its 2025 worldwide covers, Dallas future-shaping companies are in the mix. Two are Dallas-based. Another Texas company—now a $2B brand—got its start here, too.
MORE►
by Quincy Preston |
Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE►
Romulus and Remus, shown here at three months, turned six months old in April. The twin male dire wolves are the world’s first successfully de-extinct animals. Born from ancient DNA and modern science, they now roam a secure preserve in an ice age comeback story. [Photo: Colossal]
Hear the Howl: Dallas De‑Extinction Company Colossal Biosciences Brings Back Dire Wolf Using Ancient DNA
by Quincy Preston | Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
by David Seeley |
Mar 4, 2025
Before Colossal Biosciences can "de-extinct" the woolly mammoth, some small steps are in order. They've now been taken by the Colossal Woolly Mouse—a gene-edited creation with "dramatically altered coat color, texture, and thickness reminiscent of the woolly mammoth’s core phenotypes."
MORE►
by Quincy Preston and David Seeley |
Jan 21, 2025
D CEO and Dallas Innovates' Innovation Award winners are working to resurrect extinct species, launching autonomous trucks, reinventing military aircraft, and bringing AI into the physical world—and that's just the beginning. The 2025 awards showcase game-changing achievements—including Texas' first newly minted decacorn—across 17 categories of innovation. Here’s a look at the innovators leading the way.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
